If approved, the breakthrough product will bring Cerapedics' P-15 Peptide to lumbar spine fusion with a TLIF indication, making it Cerapedics' second Class III drug/device combo product ...

--Medtronic plc today announced U.S. FDA approval of a prospective, randomized pivotal clinical trial for the use of Infuse™ Bone Graft in Transforaminal Lumbar Interbody Fusion spine procedures.

KARLSRUHE, Germany--(BUSINESS WIRE)--joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online ...

FREDERICK, Md., Dec. 10, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and ...

Contemporary Endoscopic Spine Surgery brings the reader the most up-to-date ... Contemporary Clinical Decision Making In Full Endoscopic Cervical Spine Surgery; Indications And Outcomes With ...

April 30 (Reuters) - Medtronic PLC: ...

New clinical data demonstrate that Premia Spine's TOPS System provides significant health system and societal benefit versus TLIF. Contacts Joe Duraes Pazanga Health Communications jduraes ...

FREDERICK, Md., Dec. 10, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted ...